108 related articles for article (PubMed ID: 8272416)
1. Enhanced bioavailability of cefoxitin using palmitoylcarnitine. II. Use of directly compressed tablet formulations in the rat and dog.
Sutton SC; LeCluyse EL; Engle K; Pipkin JD; Fix JA
Pharm Res; 1993 Oct; 10(10):1516-20. PubMed ID: 8272416
[TBL] [Abstract][Full Text] [Related]
2. Enhanced bioavailability of cefoxitin using palmitoyl L-carnitine. I. Enhancer activity in different intestinal regions.
Sutton SC; LeCluyse EL; Cammack L; Fix JA
Pharm Res; 1992 Feb; 9(2):191-4. PubMed ID: 1553340
[TBL] [Abstract][Full Text] [Related]
3. A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen.
Sawada T; Sako K; Fukui M; Yokohama S; Hayashi M
Int J Pharm; 2003 Oct; 265(1-2):55-63. PubMed ID: 14522118
[TBL] [Abstract][Full Text] [Related]
4. 3-Amino-1-hydroxypropylidene-1,1-diphosphonate (APD): a novel enhancer of rectal cefoxitin absorption in rats.
van Hoogdalem EJ; Wackwitz AT; de Boer AG; Breimer DD
J Pharm Pharmacol; 1989 May; 41(5):339-41. PubMed ID: 2569522
[TBL] [Abstract][Full Text] [Related]
5. Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).
Christiansen ML; Holm R; Kristensen J; Kreilgaard M; Jacobsen J; Abrahamsson B; Müllertz A
Eur J Pharm Sci; 2014 Jun; 57():164-72. PubMed ID: 24239996
[TBL] [Abstract][Full Text] [Related]
6. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats.
van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD
J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123
[TBL] [Abstract][Full Text] [Related]
7. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
Lui CY; Oberle R; Fleisher D; Amidon GL
J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs.
Venkatesan N; Yoshimitsu J; Ohashi Y; Ito Y; Sugioka N; Shibata N; Takada K
Int J Pharm; 2006 Mar; 310(1-2):46-52. PubMed ID: 16439074
[TBL] [Abstract][Full Text] [Related]
9. Increases in bioavailability of poorly absorbed drug by acylcarnitine.
Tomita M; Doi N; Kimura A; Hayashi M
J Pharm Sci; 2012 Sep; 101(9):3511-7. PubMed ID: 22678774
[TBL] [Abstract][Full Text] [Related]
10. Studies on the development of colon targeted oral drug delivery systems for ornidazole in the treatment of amoebiasis.
Krishnaiah YS; Muzib YI; Rao GS; Bhaskar P; Satyanarayana V
Drug Deliv; 2003; 10(2):111-7. PubMed ID: 12746057
[TBL] [Abstract][Full Text] [Related]
11. New Perspective Enteric-Coated Tablet Dosage Form for Oral Administration of Ceftriaxone: In Vitro and In Vivo Assessments.
Maghrabia AE; Boughdady MF; Meshali MM
AAPS PharmSciTech; 2019 Sep; 20(7):306. PubMed ID: 31512022
[TBL] [Abstract][Full Text] [Related]
12. Oral formulations of adefovir dipivoxil: in vitro dissolution and in vivo bioavailability in dogs.
Cundy KC; Sue IL; Visor GC; Marshburn J; Nakamura C; Lee WA; Shaw JP
J Pharm Sci; 1997 Dec; 86(12):1334-8. PubMed ID: 9423141
[TBL] [Abstract][Full Text] [Related]
13. Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study.
Qi X; Jiang Y; Zhang H; Wu Z
J Pharm Pharmacol; 2015 Apr; 67(4):493-500. PubMed ID: 25495700
[TBL] [Abstract][Full Text] [Related]
14. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
Ahmad M; Pervaiz F
Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
[TBL] [Abstract][Full Text] [Related]
15. Dosage form design for improvement of bioavailability of levodopa VI: formulation of effervescent enteric-coated tablets.
Nishimura K; Sasahara K; Arai M; Nitanai T; Ikegami Y; Morioka T; Nakajima E
J Pharm Sci; 1984 Jul; 73(7):942-6. PubMed ID: 6088756
[TBL] [Abstract][Full Text] [Related]
16. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F.
Hu Z; Shimokawa T; Ohno T; Kimura G; Mawatari SS; Kamitsuna M; Yoshikawa Y; Masuda S; Takada K
J Drug Target; 1999; 7(3):223-32. PubMed ID: 10680978
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
Jantratid E; Prakongpan S; Amidon GL; Dressman JB
Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
[TBL] [Abstract][Full Text] [Related]
18. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
Zak AF; Ermolova OB
Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
[TBL] [Abstract][Full Text] [Related]
19. Absorption enhancement of rectally infused cefoxitin sodium by medium-chain fatty acids in conscious rats: concentration-effect relationship.
van Hoogdalem EJ; Hardens MA; de Boer AG; Breimer DD
Pharm Res; 1988 Jul; 5(7):453-6. PubMed ID: 3247317
[TBL] [Abstract][Full Text] [Related]
20. Effect of triglyceride on small intestinal absorption of cefoxitin in rats.
Yoshitomi H; Nishihata T; Frederick G; Dillsaver M; Higuchi T
J Pharm Pharmacol; 1987 Nov; 39(11):887-91. PubMed ID: 2892911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
